MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Prochlorperazine

Prochlorperazine 3mg buccal tablets

Incompatible

Stability notes for Prochlorperazine 3mg buccal tablets

Formulation not suitable for use in MCAs.  Light sensitive medicine. Store in light resistant container.  No stability data in MCAs available.

Provenance

This recommendation is based on the products Buccastem M 3mg buccal tablets (Alliance Pharmaceuticals) and prochlorperazine 3mg buccal tablets (Brown & Burk UK Ltd).

Suppliers (7) of Prochlorperazine 3mg buccal tablets
Buccastem M 3mg tablets (Alliance Pharmaceuticals Ltd)
Prochlorperazine 3mg buccal tablets (A A H Pharmaceuticals Ltd)
Prochlorperazine 3mg buccal tablets (Alliance Healthcare (Distribution) Ltd)
Prochlorperazine 3mg buccal tablets (Brown & Burk UK Ltd)
Prochlorperazine 3mg buccal tablets (Key Pharmaceuticals Ltd)
Prochlorperazine 3mg buccal tablets (Medihealth (Northern) Ltd)
Prochlorperazine 3mg buccal tablets (Medreich Plc)

Prochlorperazine 5mg tablets

Use with caution

Stability notes for Prochlorperazine 5mg tablets

Light sensitive medicine. Store in light resistant container.   Manufacturer recommends storing in original container.
Stability study supports 8 weeks in MCA provided product is protected from light. Grey discolouration can occur when exposed to light.

Provenance

This recommendation is based on the products Stemetil 5 mg tablets (Atnahs Pharma UK Ltd) and prochlorperazine 5mg tablets (Bristol Laboratories Limited).

Suppliers (14) of Prochlorperazine 5mg tablets
Prochlorperazine 5mg tablets (A A H Pharmaceuticals Ltd)
Prochlorperazine 5mg tablets (Accord-UK Ltd)
Prochlorperazine 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Prochlorperazine 5mg tablets (Almus Pharmaceuticals Ltd)
Prochlorperazine 5mg tablets (Bristol Laboratories Ltd)
Prochlorperazine 5mg tablets (Key Pharmaceuticals Ltd)
Prochlorperazine 5mg tablets (Medihealth (Northern) Ltd)
Prochlorperazine 5mg tablets (Medreich Plc)
Prochlorperazine 5mg tablets (Phoenix Healthcare Distribution Ltd)
Prochlorperazine 5mg tablets (Rudipharm Ltd)
Prochlorperazine 5mg tablets (Sigma Pharmaceuticals Plc)
Stemetil 5mg tablets (Atnahs Pharma UK Ltd)
Stemetil 5mg tablets (Necessity Supplies Ltd)
Stemetil 5mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.